1. Home
  2. BTZ vs NEO Comparison

BTZ vs NEO Comparison

Compare BTZ & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Credit Allocation Income Trust

BTZ

BlackRock Credit Allocation Income Trust

HOLD

Current Price

$10.06

Market Cap

998.6M

Sector

Finance

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$9.24

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTZ
NEO
Founded
2006
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
998.6M
1.0B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
BTZ
NEO
Price
$10.06
$9.24
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$13.38
AVG Volume (30 Days)
272.3K
2.0M
Earning Date
01-01-0001
04-28-2026
Dividend Yield
9.40%
N/A
EPS Growth
N/A
N/A
EPS
1.41
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.63
Revenue Next Year
N/A
$9.73
P/E Ratio
$7.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.70
$4.72
52 Week High
$11.18
$13.74

Technical Indicators

Market Signals
Indicator
BTZ
NEO
Relative Strength Index (RSI) 42.51 60.46
Support Level $9.70 $7.42
Resistance Level $10.42 $10.82
Average True Range (ATR) 0.09 0.40
MACD -0.03 0.04
Stochastic Oscillator 39.81 89.45

Price Performance

Historical Comparison
BTZ
NEO

About BTZ BlackRock Credit Allocation Income Trust

Blackrock Credit Allocation Income Trust is a diversified, closed-end Trust engaged in providing investment advisory and risk management solutions. Its investment objective is to seek current income, current gains, and capital appreciation. The company invests under normal market conditions, at least 80% of its assets in credit-related securities, including, but not limited to, investment-grade corporate bonds, high-yields, bank loans, preferred securities or convertible bonds, or derivatives with economic characteristics similar to these credit-related securities.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: